The Canadian firm, Microbix Biosystems, has licensed all rights and expertise concerning its thrombolytic drug, Kinlytic (urokinase), to Zydus Cadila under a milestone-cum-royalty-based pact that aims
IN VITRO DIAGNOSTICS Mergers & Acquisitions Signal Genetics LLC ChipDx LLC Predictive testing company Signal Genetics Inc. has acquired privately held ChipDX LLC (molecular diagnostics for can
The Canadian firm, Microbix Biosystems, will receive financial backing and regulatory support from Zydus Cadila of India for the proposed relaunch of the thrombolytic drug, urokinase, in the North Ame
The future looks uncertain for a joint venture that had been limbering up to build Asia's largest influenza vaccine facility in Hunan province, China. One of the joint venture partners, Canadian firm